New-onset breast discomfort has been linked to an increase in breast tissue density on mammography in postmenopausal women taking combination hormone therapy, which in turn is associated with an increased threat of breast cancer, according to the findings of a recent UCLA study.
New-onset breast discomfort has been linked to an increase in breast tissue density on mammography in postmenopausal women taking combination hormone therapy, which in turn is associated with an increased threat of breast cancer, according to the findings of a recent UCLA study.
Carolyn J. Crandall, MD, MS, and colleagues used data from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study, which involved mammograms for almost 600 women between the ages of 45 and 64 years.
Compared with women without new-onset breast discomfort, the researchers found that women taking estrogen/progestin combination therapy with new-onset discomfort had a significant increase in percent breast density at 12 months (0.6% vs. 3.9%; β=0.033, P<0.001).
Crandall CJ, Karlamangla A, Huang MH, et al. Association of new-onset breast discomfort with an increase in mammographic density during hormone therapy. Arch Intern Med. 2006;166:1578-1584.
Commentary by Victoria Green, MD, MBA, JD, Associate Professor, Department of Gynecology and Obstetrics, Emory University, Atlanta, Ga.:
Although the study involved a short surveillance period, this appears to be the first data gathered in a placebo-controlled, randomized, blinded design to review self-reported breast discomfort where increased mammographic breast density was also linked to late age at first delivery and increased postmenopausal BMI. Ultimately, further research must determine whether increased mammographic density in the context of hormone therapy definitely heralds an increased risk of breast cancer.
Long-term mortality risks for women with adverse pregnancy outcomes
April 19th 2024A recent study revealed that women who experience major adverse pregnancy outcomes face heightened long-term mortality risks, shedding light on the need for comprehensive understanding and preventative measures in women's health.
Read More
Unlocking placenta accreta spectrum with single-cell gene targets
April 18th 2024Discover how cutting-edge single-cell RNA sequencing unveils molecular insights into placenta accreta spectrum disorders, potentially revolutionizing diagnostics and treatments for this life-threatening pregnancy complication.
Read More
Genetics associated with reproductive traits and uterine leiomyomata
April 17th 2024Investigating genetic correlations and shared loci sheds light on potential causal relationships between reproductive traits and uterine leiomyomata, offering insights into their complex interplay and urging further mechanistic exploration.
Read More